Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Recruiting now

Conditions studied: Carcinoma, Hepatocellular

In brief

This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.

Key facts

Study ID

NCT03894917

Run by

The University of Texas Health Science Center at San Antonio

People needed

84

Starts

2019-09-13

Expected to finish

2027-12-01

Last updated by the study team

2026-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or radiographically (CT or MRI) confirmed newly diagnosed hepatocellular carcinoma.
• Age 18 years and older.
• Patients with advanced, unresectable HCC as determined by the treating physician.

You may not qualify if…

• Patients with resectable HCC who are still candidates for locoregional therapy
• Patients receiving prior systemic or locoregional therapy

Where it is running

• Mays Cancer Center — San Antonio, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.